Icon

MEKTOVI (nda210498)- (15MG)

BINIMETINIB ARRAY BIOPHARMA INC
15MG
Yes No
2033-Oct-18 2023-Jun-27
None None
None No
MEKTOVI is a kinase inhibitor indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test.
0 2 0
Total Other Developers 6
Drugs with Suitability No
15MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.